Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
It is a chromogenic complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is administered by inhalation for the prevention of asthma and atopic rhinitis, orally in food allergies and topically in dermatology and ophthalmology.
At the date of last update we found no published data on its excretion in breast milk.
The small dose and low plasma absorption of most inhaled (buccal or nasal), ophthalmologic or topical dermatologic preparations make the passage of significant amounts into breast milk unlikely.
Their low oral bioavailability makes it difficult for them to pass into infant plasma from ingested breast milk, except in premature infants and the immediate neonatal period in which there may be greater intestinal permeability.
There is consensus among experts and scientific societies that sodium cromoglycate is compatible with breastfeeding(Hale, LactMed, Brigggs 2015, Nelson 2001, National Asthma Education 2004, Powrie 2006, Nice 2004) due to its minimal absorption and low plasma levels in the mother. (AEMPS 2013, Davis 2015)
WHO 2002 essential drug list: compatible with breastfeeding. (WHO 2002)